Making Sense of Data: A Self-Instruction Manual on the Interpretation of Epidemiological Data

Making Sense of Data: A Self-Instruction Manual on the Interpretation of Epidemiological Data

Volumn , Issue , 2009, Pages 1-384

  Abramson, J H ^a   Abramson, Z H ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

Associations; Causality; Community medicine; Confounding; Data interpretation; Epidemiological concepts; Meta analysis; Research; Self instruction; Validity

Indexed keywords

EID: 84940547942     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195145250.001.0001     Document Type: Book

References (290)

1. Abramson JH. Meta-analysis: a review of pros and cons. Public Health Reviews 18: 1-47, 1990/91.
2. Abramson JH. Community-oriented primary care-strategy, approaches and practice: a review. Public Health Reviews 16: 35-98, 1988.
3. Abramson JH. Age-standardization in epidemiological data. International Journal of Epidemiology 24: 238-239, 1995.
4. Abramson JH, Abramson ZH. Survey methods in community medicine: epidemiological research, programme evaluation, clinical trials, 5th edn. Edinburgh: Churchill Livingstone, 1999.
5. Abramson, JH, Gahlinger PM. Computer programs for epidemiologists: PEPI version 4.0. Salt Lake City: Sagebrush Press, 2001.
6. Abramson JH, Hopp C. The control of cardiovascular risk factors in the elderly. Preventive Medicine 5: 32-47, 1976.
7. Abramson JH, Hopp C, Epstein LM. The epidemiology of varicose veins: a survey in western Jerusalem. Journal of Epidemiology and Community Health 35: 213-217, 1981.
8. Abramson JH, Kark SL, Palti H. The epidemiological basis for community-oriented primary care. In: Epidemiologie et médecine communautaire (Lellouche J, ed). Paris: INSERM, 1983, pp. 231-263.
9. Abramson JH, Sacks MI, Cahana E. Death certificate data as an indication of the presence of certain common diseases at death. Journal of Chronic Diseases 24: 417-431, 1971.
10. Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey, 1996. Vital and Health Statistics 10(200), Hyattsville, MD: National Center for Health Statistics, 1999.
11. Altman DG. Practical statistics for medical research. London: Chapman & Hall, 1991.
12. Altman DG. Clinical trials and meta-analyses. In: Statistics with confidence, 2nd edn. (Altman DG, Machin D, Bryant TN, Gardner MJ, eds). BMJ Books, 2000, pp. 120-138.
13. Altman DG, Machin D, Bryant TN, Gardner MJ. Statistics with confidence. 2nd edn. BMJ Books, 2000.
14. Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M, de Schaepdryver A, Dollery C, Fagard R, Forette F, Forte J, Hamdy R, Henry JF, Joossens JV, Leonetti G, Lund-Johansen P, O'Malley K, Petrie J, Strasser T, Tuomilehto J, Williams B. Mortality and morbidity results from the European Working Party in High Blood Pressure in the Elderly trial. Lancet 1: 1349-1354, 1985.
15. Andersen JW, Harrington D. Meta-analyses need new publication standards. Journal of Clinical Oncology 10: 878-880, 1992.
16. Anderson S, Auquier WW, Hauck WW, Oakes D, Vandaele W, Weissberg HI. Statistical methods for comparative studies. New York: Wiley, 1980.
17. Andrews G, MacMahon SW, Austin A, Byrne DG. Hypertension: comparison of drug and non-drug treatments. British Medical Journal 284: 1523-1526, 1982.
18. Armitage P, Berry G. Statistical methods in medical research, 3rd edn. Oxford: Blackwell, 1994.
19. Bailey KR. Inter-study differences: how should they influence the interpretation and analysis of results? Statistics in Medicine 6: 351-358, 1987.
20. Ban R, Peritz E. Longitudinal study of borderline hypertension. Paper presented at International Symposium on Hypertension Control in the Community, Tel Aviv, Nov. 1982.
21. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. Journal of the American Medical Association 279: 1566-1570, 1998.
22. Bartko JJ. Measures of agreement: a single procedure. Statistics in Medicine 13: 737-745, 1994.
23. Begg CB, Pilote L, McGlave PB. Bone marrow transplantation versus chemotherapy in acute non-lymphocytic leukemia: a meta-analytic review. European Journal of Cancer and Clinical Oncology 25: 1519-1523, 1989.
24. Bennett J, Breen C, Traverso H, Agha SB, Macia J, Boring J. Circumcision and neonatal tetanus: disclosure of risk and its reduction by topical antibiotics. International Journal of Epidemiology 28: 263-266, 1999.
25. Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. American Journal of Epidemiology 132: 612-628, 1990.
26. Berlin JA, Laird NM, Sacks HS, Chalmers TC. A comparison of statistical methods for combining event rates from clinical trials. Statistics in Medicine 8: 141-151, 1989.
27. Berry G, Armitage P. Mid-P confidence intervals: a brief review. The Statistician 44: 417-423, 1995.
28. Boden WE. Meta-analysis in clinical trial reporting: has a tool become a weapon? American Journal of Cardiology 69: 681-686, 1992.
29. Boyce WJ, Vessey MP. Rising incidence of fracture of the proximal femur. Lancet 1: 150-151, 1985.
30. Breslow NE, Day NE. Statistical methods in cancer research, Vol. 1: The analysis of casecontrol studies. Lyon: International Agency for Research on Cancer, 1980.
31. Breslow NE, Day NE. Statistical methods in cancer research, Vol. II: The design and analysis of cohort studies. Lyon: International Agency for Research on Cancer, 1987.
32. Brett M, Barker DJP. The world distribution of gallstones. International Journal of Epidemiology 5: 335-341, 1976.
33. Bross IDJ. Spurious effects from an extraneous variable. Journal of Chronic Diseases 19: 637-647, 1966.
34. Bross IDJ. Pertinency of an extraneous variable. Journal of Chronic Diseases 20: 487-495, 1967.
35. Brownson RC, Petitti DB (eds). Applied epidemiology: theory to practice. New York: Oxford University Press.
36. Brownson RC, Novotny TE, Perry MC. Cigarette smoking and adult leukemia: a metaanalysis. Archives of Internal Medicine 153: 469-475, 1993.
37. Brunekreef B, Fischer P, Remijn B, van der Lende R, Schouten J, Quanjer P. Indoor air pollution and its effect on pulmonary function of adult non-smoking women: III. Passive smoking and pulmonary function. International Journal of Epidemiology 14: 227-230, 1985.
38. Bulpitt CJ, Beilin LJ, Clifton P, Coles EC, Dollery CT, Gear JSS, Harper GS, Johnson BF, Munro-Faure AD. Risk factors for death in treated hypertensive patients: report from the D.H.S.S. Hypertension Care Computing Project. Lancet 2: 134-137, 1979.
39. Byrt T, Bishop J, Carlin JB. Bias, prevalence and kappa. Journal of Clinical Epidemiology 46: 423-429, 1993.
40. Campbell DT. Factors relevant to the validity of experiments in social settings. In: Program evaluation in the health fields (Schulberg HC, Sheldon A, Baker F, eds). New York: Behavioral Publications, 1969, pp. 165-185.
41. Campbell DT, Stanley JC. Experimental and quasi-experimental designs for research. Chicago: Rand McNally, 1966.
42. Canner PL. An overview of six clinical trials of aspirin in coronary heart disease. Statistics in Medicine 6: 255-263, 1987.
43. Carroll L. Alice's adventures in Wonderland. 1865.
44. Carroll L. Through the looking glass (and what Alice found there). 1872.
45. Chalmers I, Adams M, Dickersin K, Hetherington J, Tarnow-Mordi W, Meinert C, Tonascia S, Chalmers TC. A cohort study of summary reports of clinical trials. JAMA 263: 1401-1405, 1990.
46. Chalmers I, Altman DG (eds). Systematic reviews. London: BMJ Publishing Group, 1995.
47. Chalmers I, Haynes B. Reporting, updating and correcting systematic reviews of the effects of health care. In: Systematic reviews (Chalmers I, Altman DG, eds). London: BMJ Publishing Group, 1995, pp. 86-95.
48. Chalmers TC. Problems induced by meta-analyses. Statistics in Medicine 10: 971-980, 1991.
49. Chalmers TC, Levin H, Sacks HR, Reitman D, Berrier J, Ngalingam R. Meta-analysis of clinical trials as a scientific discipline: I. Control of bias and comparison with large cooperative trials. Statistics in Medicine 6: 315-325, 1987.
50. Chalmers TC, Smith H, Blackburn B, Silverman B, Schroeder B, Reitman D, Ambroz A. A method for assessing the quality of a randomized clinical trial. Controlled Clinical Trials 2: 31-49, 1981.
51. Chapman S, Cornwall J, Righetti J, Sung L. Preventing dog bites in children: randomised controlled trial of an educational intervention. British Medical Journal 320: 1512-1513, 2000.
52. Choi BCK, de Guia NA, Walsh P. Look before you leap: stratify before you standardize. American Journal of Epidemiology 149: 1087-1096, 1999.
53. Choi BCK, Pak AWP. Bias, overview. In: Encyclopedia of biostatistics, Vol. 1 (Armitage P, Colton T, eds). Chichester: Wiley, 1998, pp. 331-338.
54. Clark VA, Aneshensel CS, Frerichs RR, Morgan TM. Analysis of non-response in a prospective study of depression in Los Angeles County. International Journal of Epidemiology 12: 193-198, 1983.
55. Cochran WG. Planning and analysis of observational studies. New York: Wiley, 1983, p. 20.
56. Cochrane AL, St Leger AS, Moore F. Health service 'input' and mortality 'output' in developed countries. Journal of Epidemiology and Community Health 32: 200-205, 1978.
57. Cole TJ. The influence of heights on the decline in ventilatory function. International Journal of Epidemiology 3: 145-152, 1974.
58. Collins R, Gray R, Godwin J, Peto R. Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. Statistics in Medicine 6: 245-250, 1987.
59. Collins R, Peto R, MacMahon S, Herbert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 335: 827-838, 1990.
60. Connell FA, Koepsell TD. Measures of gain in certainty from a diagnostic test. American Journal of Epidemiology 121: 744-753, 1985.
61. Connor E, Mullan F (eds). Community-oriented primary care: new directions for health service delivery. Washington, D.C.: National Academy Press, 1983.
62. Cook TD, Campbell DT. Quasi-experimentation: design and analysis issues for field settings. Chicago: Rand McNally, 1979.
63. Copas JB, Shi JQ. Reanalysis of epidemiological evidence on lung cancer and passive smoking. British Medical Journal 320: 417-418, 2000.
64. Coreil J, Augustin A, Holt E, Halsey NA. Use of ethnographic research for instrument development in a case-control study of immunization use in Haiti. International Journal of Epidemiology 18: S33-S37, 1989.
65. Cox DR, Oakes D. Analysis of survival data. London: Chapman & Hall, 1984.
66. Dales LD, Ury HK. An improper use of statistical significance testing in studying covariables. International Journal of Epidemiology 4: 373-375, 1978.
67. Daniel WW. Biostatistics: a foundation for analysis in the health sciences, 6th edn. New York: Wiley, 1995.
68. Davies TW, Williams DR, Whitaker RH. Risk factors for undescended testis. International Journal of Epidemiology 4: 169-170, 1986.
69. DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 6: 341-348, 1987.
70. Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ont. Clinical epidemiology rounds. Canadian Medical Association Journal 129: 429-432, 559-564, 705-710, 832-835, 947-954, 1093-1099, 1983.
71. Depue RH. Maternal and gestational factors affecting the risk of cryptorchidism and inguinal hernia. International Journal of Epidemiology 13: 311-318, 1984.
72. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 7: 177-188, 1986.
73. De Semir V. What is newsworthy? Lancet 347: 1163-1166, 1996.
74. Detels R. Epidemiology: the foundation of public health. In: Oxford textbook of public health, 3rd edn., Vol. 2: The methods of public health (Detels R, Holland WW, McEwen J, Omenn GS, eds). Oxford: Oxford University Press, 1997, pp. 501-506.
75. Detels R, McEwan J, Beaglehole R, Tanaka H (eds). Oxford textbook of public health, 4th edn., Vol. 2: The methods of public health. Oxford: Oxford University Press, 2001.
76. Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbe KA. Incorporating variations in the quality of individual randomized trials into meta-analysis. Journal of Clinical Epidemiology 45: 255-265, 1992.
77. Dickersin K, Hewitt P, Mutch L, Chalmers I, Chalmers TC. Comparison of MEDLINE searching with a perinatal clinical trials database. Controlled Clinical Trials 6: 306-317, 1985.
78. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. In: Systematic reviews (Chalmers I, Altman DG, eds). London: BMJ Publishing Group, 1995, pp. 17-36.
79. Ducimitiere P, Richard JL, Pequignot GP, Warnet JM. Varicose veins: a risk factor for atherosclerotic disease in middle-aged men? International Journal of Epidemiology 10: 329-335, 1981.
80. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 337: 867-872, 1991.
81. Ellenberg JH, Nelson KB. Sample selection and the natural history of disease: studies of febrile seizures. JAMA 243: 1337-1340, 1980.
82. Elwood JM, Lee JAH, Walter SD, Mo T, Green AES. Relationship of melanoma and other skin cancer mortality to latitude and ultraviolet radiation in the United States and Canada. International Journal of Epidemiology 3: 325-332, 1974.
83. Engels EA, Schmid CH, Terrin N, Olkin I, Lau J. Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. Statistics in Medicine 19: 1707-1728, 2000.
84. Epstein LM. Validity of a questionnaire for diagnosis of peptic ulcer in an ethnically heterogeneous population. Journal of Chronic Diseases 22: 49-55, 1969.
85. Evans AS, Wells AV, Ramsay F, Drabkin P, Palmer K. Poliomyelitis, rubella and dengue antibody survey in Barbados. A follow-up study. International Journal of Epidemiology 8: 235-241, 1979.
86. Eysenck HJ. An exercise in mega-silliness. American Psychologist 35: 517, 1978.
87. Eysenck HJ. Problems with meta-analysis. In: Systematic reviews (Chalmers I, Altman DG, eds). London: BMJ Publishing Group, 1995, pp. 64-74.
88. Fawzi WW, Chalmers TC, Herrera MG, Mosteller F. Vitamin A supplementation and child mortality: a meta-analysis. JAMA 269: 898-903, 1993.
89. Feinstein AR. Clinical biostatics. St. Louis: Mosby, 1977, p. 91.
90. Feinstein AR. Clinical epidemiology: the architecture of clinical research. Philadelphia: W. B. Saunders, 1985.
91. Felson DT. Bias in meta-analytic research. Journal of Clinical Epidemiology 45: 885-892, 1992.
92. Fioretti F, Tavani A, Gallus S, Franceschi S, Negri E, La Vecchia C. Case control study of thyroid cancer in northern Italy: attributable risk. International Journal of Epidemiology 28: 626-630, 1999.
93. Fisher KJ, Glasgow RE, Terborg JR. Work site smoking cessation: a meta-analysis of longterm quit rates from controlled studies. Journal of Occupational Medicine 32: 429-439, 1990.
94. Fleiss JL. Statistical methods for rates and proportions, 2nd edn. New York: Wiley, 1981.
95. Fleiss JL. Significance tests have a role in epidemiologic research: reactions to A. M. Walker, American Journal of Public Health 76: 559-560, 1986a.
96. Fleiss JL. Dr. Fleiss responds. American Journal of Public Health 76: 1033-1034, 1986b.
97. Fleiss JL. The design and analysis of clinical experiments. New York: Wiley, 1986c.
98. Fleiss JL, Gross AJ. Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: a critique. Journal of Clinical Epidemiology 44: 127-139, 1991.
99. Forman MR, Graubard BI, Hoffman HJ, Beren R, Harley EE, Bennett P. The Pima Infant Feeding Study: breastfeeding and respiratory infections during the first year of life. International Journal of Epidemiology 13: 447-453, 1984.
100. Frankel A, Gunnell DJ, Peters DJ, Maynard M, Smith GD. Childhood energy intake and adult mortality from cancer: the Boyd Orr cohort study. British Medical Journal 316: 499-504, 1998.
101. Friedman GD. Primer of epidemiology, 2nd edn. New York: McGraw-Hill, 1980.
102. Furberg CD, Morgan TM. Lessons from overviews of cardiovascular trials. Statistics in Medicine 6: 295-303, 1987.
103. Gershman K. Case-control study of which dogs bite (abstract). American Journal of Epidemiology 138: 593, 1992.
104. Gershman KA, Sacks JJ, Wright JC. Which dogs bite? A case-control study of risk factors. Pediatrics 93: 913-917, 1994.
105. Giagnoni E, Secchi MB, Wu SC, et al. Prognostic value of exercise EKG testing in asymptomatic normotensive individuals. New England Journal of Medicine 309: 1085-1089, 1983.
106. Gifford RH, Feinstein AR. A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction. New England Journal of Medicine 280: 351-357, 1969.
107. Gillam S, Miller R. COPC-a public health experiment in primary care. London: King's Fund, 1997.
108. Glass GV, McGaw B, Smith ML. Meta-analysis in social research. Beverly Hills, California: Sage Publications, 1981.
109. Glass GV, Smith ML. Reply to Eysenck. American Psychologist 35: 517-519, 1978.
110. Godfrey CM, Morgan P. A controlled trial of the theory of acupuncture in musculoskeletal pain. Journal of Rheumatology 5: 121-124, 1978.
111. Gofin J, Kark E, Mainemer N, Kark SL, Abramson JH, Hopp C, Epstein LM. Prevalence of selected health characteristics of women and comparisons with men: a community health survey in Jerusalem. Israel Journal of Medical Sciences 17: 145-149, 1981.
112. Goldbourt U, Kark JD. The epidemiology of coronary heart disease in the ethnically and culturally diverse population of Israel. Israel Journal of Medical Sciences 18: 1077-1097, 1982.
113. Goldstein R. Epidemiological software. In: Encyclopedia of epidemiologic methods (Gail MH, Benichou J, eds). New York: Wiley, 2000.
114. Goodman SN. Have you ever meta-analysis you didn't like? Annals of Internal Medicine 114: 244-246, 1991.
115. Goodwin PJ, Boyd NF. Mammographic parenchymal pattern and breast cancer risk: a critical appraisal of the evidence. American Journal of Epidemiology 127: 1097-1107, 1988.
116. Gray A, Berlin JA, McKinlay JB, Longcope C. An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. Journal of Clinical Epidemiology 44: 671-684, 1991.
117. Green, M. Use of predictive value to adjust relative risk estimates biased by misclassification of outcome status. American Journal of Epidemiology 117: 98-105, 1983.
118. Greenhaigh T, Taylor R. How to read a paper: papers that go beyond numbers (qualitative research). British Medical Journal 315: 740, 1997.
119. Greenland S (ed). Evolution of epidemiologic ideas: annotated readings on concepts and methods. Chestnut Hill, Massachusetts: Epidemiology Resources, 1987.
120. Greenland S. Induction versus Popper: substance versus semantics. International Journal of Epidemiology 37: 543-548, 1998a.
121. Greenland S. Meta-analysis. In: Modern epidemiology, 2nd edn. (Rothman KJ, Greenland S). Philadelphia: Lippincott-Raven, 1998b, pp. 643-673.
122. Greenland S, Salvan A. Bias in the one-step method for pooling study results. Statistics in Medicine 9: 247-252, 1990.
123. Gupta PC, Bhonsle RB, Mehta FS, Pindborgh JJ. Mortality experience in relation to tobacco chewing and smoking habits from a 10-year follow-up study in Ernakulam District, Kerala. International Journal of Epidemiology 13: 184-187, 1984.
124. Hammond EC, Selikoff IJ, Seidman H. Asbestos exposure, cigarette smoking and death rates. Annals of the New York Academy of Sciences 330: 473-495, 1979.
125. Hedges LV. Commentary. Statistics in Medicine 6: 381-385, 1987.
126. Hedges LV, Olkin I. Statistical methods for meta-analysis. Orlando, Florida: Academic Press, 1985.
127. Heggenhaugen H, Pedersen D. Beyond quantitative measures: the relevance of anthropology for public health. In: Oxford textbook of public health, 3rd edn., Vol 2: The methods of public health (Detels R, Holland WW, McEwen J, Omenn GS, eds). New York, Oxford University Press, 1997, pp. 815-828.
128. Held PH, Yusuf F, Furburg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. British Medical Journal 299: 1187-1192, 1989.
129. Hennekens CH, Buring JE. Epidemiology in medicine. Boston: Little, Brown, 1987.
130. Hill AB. Statistical methods in clinical and preventive medicine. Edinburgh: Livingstone, 1962.
131. Hill C, Benhamou E. Age-standardization in epidemiological data. International Journal of Epidemiology 24: 241-242, 1995.
132. Hoddinott P, Pill R. Qualitative study of decisions about infant feeding among women in east end of London. British Medical Journal 318: 30-34, 1999.
133. Holme I. Relation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomised trials: use of meta-analysis. British Heart Journal 69 (Suppl).: S42-47, 1993.
134. I-Kuei Lin, L. A concordance correlation coefficient to evaluate reproducibility. Biometrics 45: 255-268, 1989.
135. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. Annals of Internal Medicine 126: 36-47, 1997.
136. Iyengar S, Greenhouse JB. Selection models and the file-drawer problem. Statistical Science 3: 109-135, 1988.
137. Jacobsen R, Bostofte E, Engholm G, Hansen J, Olsen JH, Skakkebaek NE, Moller H. Risk of testicular cancer in men with abnormal semen characteristics: cohort study. British Medical Journal 321: 789-92, 2000.
138. Jadad AR, Moher M, Browman GP, Booker L, Sigouin C, Fuentes M, Stevens R. Systematic reviews and meta-analyses on treatment of asthma: critical evaluation. British Medical Journal 320: 537-540, 2000.
139. Jenicek M. Meta-analyses in medicine: where we are and where we want to go. Journal of Clinical Epidemiology 42: 35-44, 1989.
140. Jones DR. Meta-analysis of observational epidemiological studies: a review. Journal of the Royal Society of Medicine 85: 165-169, 1992.
141. Kabat GC, Howson CP, Wynder EL. Beer consumption and rectal cancer. International Journal of Epidemiology 15: 494-501, 1986.
142. Kahn HA. The Dorn study of smoking and mortality among U.S. veterans: report on eight and one-half years of observation. In: Epidemiological approaches to the study of cancer and other chronic diseases (Haenszel W, ed). National Cancer Institute Monograph 19, 1966.
143. Kahn HA, Herman JB, Medalie JH, Neufeld HN, Riss E, Goldbourt U. Factors related to diabetes incidence: a multivariate analysis of two years' observation on 10,000 men. The Israel Ischemic Heart Disease Study. Journal of Chronic Diseases 23: 617-629, 1971.
144. Kahn HA, Sempos CT. Statistical methods in epidemiology. New York: Oxford University Press, 1989.
145. Kark S, Kark E. Promoting community health: from Pholela to Jerusalem. Johannesburg: Witwatersrand University Press, 1999.
146. Kark SL. Epidemiology and community medicine. New York: Appleton-Century-Crofts, 1974.
147. Kark SL. The practice of community-oriented primary health care. New York: Appleton-Century-Crofts, 1981.
148. Kark SL, Gofin J, Abramson JH, Makler A, Mainemer N, Kark E, Epstein LM, Hopp C. Prevalence of selected health characteristics of men: a community health survey in Jerusalem. Israel Journal of Medical Sciences 15: 732-741, 1979.
149. Kark SL, Kark E, Abramson JH, Gofin J (eds). Atencion primaria orientada a la comunidad (APOC). Barcelona: Ediciones Doyma S.A., 1994.
150. Kelsey JL, Thompson WD, Evans AS. Methods in observational epidemiology. New York: Oxford University Press, 1986.
151. Khaw K-T, Rose G. Population study of blood pressure and associated factors in St Lucia, West Indies. International Journal of Epidemiology 11: 372-377, 1982.
152. Klein S, Simes J, Blackburn GL. Total parenteral nutrition and cancer clinical trials. Cancer 58: 1378-1386, 1986.
153. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, California: Lifetime Learning Publications, 1982.
154. Kono S, Ikeda M, Tokudome S, Nishizumi M, Kuratsune M. Alcohol and mortality: a cohort study of male Japanese physicians. International Journal of Epidemiology 15: 527-532, 1986.
155. Kreiger N, Gross A, Hunter G. Dietary factors and fracture in postmenopausal women: a case-control study. International Journal of Epidemiology 21: 953-958, 1992.
156. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomized study of screening for colorectal cancer with faecal-occult blood test. Lancet 348: 1467-1471, 1996.
157. Lancet. Editorial: Shall we nim a horse? Lancet 345: 1585-1586, 1995.
158. Landis JR, Sharp TJ, Kuritz SJ, Koch GG. Mantel-Haenszel methods. In: Encyclopedia of epidemiologic methods (Gail MH, Benichou J, eds). Chichester: Wiley, 2000, pp. 499-512.
159. Landman JT, Dawes RM. Psychotherapy outcome: Smith and Glass' conclusions stand up under scrutiny. American Psychologist 37: 504-516, 1982.
160. Langman MJS, Cheng KK, Gilman EA, Lancashire RJ. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. British Medical Journal 320: 1642-1645, 2000.
161. Last JM (ed). A dictionary of epidemiology, 4th edn. New York: Oxford University Press, 2001.
162. Last JM, Foege WH. International health. In: Maxcy-Rosenau public health and preventive medicine (Last JM, ed), 12th edn. Norwalk, Connecticut: Appleton-Century-Crofts, 1986.
163. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analyses of therapeutic trials for myocardial infarction. New England Journal of Medicine 327: 248-254, 1992.
164. Lee J. An insight on the use of multiple logistic regression analysis to estimate association between risk factor and disease occurrence. International Journal of Epidemiology 15: 22-29, 1986.
165. Lehtonen A, Luutnen S. Serum lipids of very old people without dementia or with different types of senile dementia. In: 8th Scandinavian Congress of Gerontology: congress proceedings. Tampere: Societas Gerontologica Fennica, 1986, pp. 489-491.
166. Lellouch J, Rokotovao R. Estimation of risk as a function of risk factors. International Journal of Epidemiology 5: 349-352, 1976.
167. Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. American Journal of Epidemiology 115: 92-106, 1982.
168. Liberati A, Himel HN, Chalmers TC. A quality assessment of randomized clinical trials of primary treatment of breast cancer. Journal of Clinical Oncology 4: 942-951, 1986.
169. Lichtenstein MJ, Mulrow CD, Elwood PC. Guidelines for reading case-control studies. Journal of Chronic Diseases 40: 893-903, 1987.
170. Light RJ. Accumulating evidence from independent studies: what we can win and what we can lose. Statistics in Medicine 6: 221-228, 1987.
171. Lilienfeld AM, Lilienfeld DE. Foundations of epidemiology, 2nd edn. New York: Oxford University Press, 1980.
172. Lindquist C. Risk factors in lip cancer. American Journal of Epidemiology 109: 521-530, 1979.
173. Lipscomb JA, Satin KP, Neutra RR. Reported symptom prevalence rates from comparison populations in community-based environmental studies. Archives of Environmental Health 47: 263-269, 1992.
174. Loevinsohn BP. Health education interventions in developing countries: a methodological review of published articles. International Journal of Epidemiology 19: 788-794, 1990.
175. MacMahon B, Pugh TF, Ipsen J. Epidemiologic methods. Boston: Little, Brown, 1960.
176. Maffei FHA, Magaldi C, Pinho SZ, Lastoria S, Pinho W, Yoshida WB, Rollo HA. Varicose veins and chronic venous insufficiency in Brazil: prevalence among 1755 inhabitants of a country town. International Journal of Epidemiology 15: 210-217, 1986.
177. McMichael AJ, Hetzel BS. An epidemiological study of the mental health of Australian university students. International Journal of Epidemiology 3: 125-134, 1974.
178. McNeil D. Epidemiological research methods. New York: Wiley, 1996.
179. Mainland D. Elementary medical statistics, 2nd edn. Philadelphia: W. B. Saunders, 1964.
180. Mazzuca SA. Does patient education in chronic disease have therapeutic value? Journal of Chronic Diseases 35: 521-529, 1983.
181. Meade TW, Brennan PJ. Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomized controlled trial. British Medical Journal 321: 13-17, 2000.
182. Meijer WS, Schmitz PIM, Jeekel J. Meta-analysis of randomized, controlled clinical trials of antibiotic prophylaxis in biliary tract surgery. British Journal of Surgery 77: 283-290, 1990.
183. Miettinen OS, Cook EF. Confounding: essence and detection. American Journal of Epidemiology 114: 593-603, 1991.
184. Mittlboeck M, Schemper M. Explained variation for logistic regression. Statistics in Medicine 14: 1987-1997, 1996.
185. Morris JN. Uses of epidemiology, 3rd edn. Edinburgh: Churchill Livingstone, 1975.
186. Mulder PGH, Garretsen HFL. Are epidemiological and sociological surveys a proper instrument for detecting true problem drinkers? (The low sensitivity of an alcohol survey in Rotterdam). International Journal of Epidemiology 12: 442-444, 1983.
187. National Center for Health Statistics. Health, United States, 1999. Hyattsville, Maryland: U.S. Department of Health and Human Services, 1999.
188. National Center for Health Statistics. Health, United States, 2000. Hyattsville, Maryland: U.S. Department of Health and Human Services, 2000.
189. Naylor CD. Two cheers for meta-analysis: problems and opportunities in aggregating results of clinical trials. Canadian Medical Association Journal 138: 891-895, 1988.
190. Niswander K, Henson G, Elbourne D, Chalmers I, Redman C, MacFarlane A, Tizard P. Adverse outcome of pregnancy and the quality of obstetric care. Lancet 2: 827-831, 1984.
191. Nutting PA (ed). Community-oriented primary care: from principle to practice. Washington, D.C.: U.S. Department of Health and Human Services. HRSA Publication No. HRS-A-PE 86-1, 1987.
192. Nyyssonen K, Parviainen MT, Salonen R, Tuomilehto J, Salonen JT. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. British Medical Journal 314: 634-638, 1997.
193. O'Rourke K, Detsky AS. Meta-analysis in medical research: strong encouragement for higher quality in individual research efforts. Journal of Clinical Epidemiology 42: 1021-1026, 1989.
194. Orwin RG. A fail-safe N for effect size. Journal of Educational Statistics 8: 157-159, 1983.
195. Ostfeld AM, Shekelle RB, Klawans H, et al. Epidemiology of stroke in an elderly welfare population. American Journal of Public Health 64: 450-458, 1974.
196. Owen R. Reader bias. Journal of the American Medical Association 247: 2533-2534, 1982.
197. Oxman AD, Guyatt GH. The science of reviewing research. Annals of the New York Academy of Sciences 703: 125-131, 1993.
198. Palti H. Use of control groups in evaluating the effectiveness of community health programs in primary care. Israel Journal of Medical Sciences 19: 756-759, 1983.
199. Palti H, Adler B, Tepper D. An early infant stimulation program in the maternal and child health service-evaluation at 5 years of age-preliminary findings. In: Stimulation and intervention in infant development (Tamir D, ed). London: Freund, 1986, pp. 195-201.
200. Parkkari J, Kannus P, Niemi S, Koskinen S, Palvanen M, Vuori I, Jarvinen M. Childhood deaths and injuries in Finland in 1971-1995. International Journal of Epidemiology 29: 516-523, 2000.
201. Pearson K. The grammar of science. London: Scott, 1892.
202. Petitti DB. Meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine. New York: Oxford University Press, 1994.
203. Peto R. Why do we need systematic overviews of randomized trials? Statistics in Medicine 6: 233-240, 1987a.
204. Peto R. Discussion. Statistics in Medicine 6: 241-244, 1987b.
205. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: I. Introduction and design. British Journal of Cancer 34: 585-612, 1976.
206. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. British Journal of Cancer 35: 1-39, 1977.
207. Philipp R, Evans EJ, Hughes AO, Grisdale SK, Enticott RG, Jephcott AE. Health risks of snorkel swimming in untreated water. International Journal of Epidemiology 14: 624-627, 1985.
208. Pintos J, Franco EL, Kowalski LP, Oliveira BV, Curado MP. Use of wood stoves and cancer of the upper aero-digestive tract: a case-control study. International Journal of Epidemiology 27: 936-940, 1998.
209. Pocock SJ, Hughes MD. Estimation issues in clinical trials and overviews. Statistics in Medicine 9: 657-671, 1990.
210. Pope C, Mays C (eds). Qualitative research in health care, 2nd edn. London: BMJ Publishing Group, 2000.
211. Popiela T, Jedrychowski W, Filipek A, Dolzycki E, Kulig J, Olszanecki S. Validity of questionnaire criteria in mass screening for the diagnosis of peptic ulcer. International Journal of Epidemiology 5: 251-253, 1976.
212. Poulter NR, Sever OS. Intervention in high risk groups: blood pressure. In: Coronary heart disease epidemiology: from aetiology to public health (Marmot M, Elliott P, eds). Oxford: Oxford University Press, 1992, pp. 325-342.
213. Preti P, Miotto P. Suicide and unemployment in Italy, 1982-1994. Journal of Epidemiology and Community Health 53: 694-701, 1999.
214. Rhyne R, Bogue R, Kukulka G, Fulmer H. Community-oriented primary care: health care for the 21st century. Washington, D.C.: American Public Health Association, 1998.
215. Ritchie K, Jildea D, Robine J-M. The relationship between age and the prevalence of senile dementia: a meta-analysis of recent data. International Journal of Epidemiology 21: 763-769, 1992.
216. Roberts RS, Spitzer WO, Delmore T, Sackett DL. An empirical demonstration of Berkson's bias. Journal of Chronic Diseases 31: 119-128, 1978.
217. Rona RJ, Chinn S, Florey CduV. Exposure to cigarette smoking and children's growth. International Journal of Epidemiology 14: 402-409, 1985.
218. Rona RJ, Swan AV, Altman DG. Social factors and height of primary schoolchildren in England and Scotland. Journal of Epidemiology and Community Health 32: 147-154, 1978.
219. Roper HP, David TJ. Decline in deaths from choking on food in infancy: an association with change in feeding practice? Journal of the Royal Society of Medicine 80: 2-3, 1987.
220. Rosenthal R. The "file drawer problem" and tolerance for null results. Psychological Bulletin 85: 185-193, 1979.
221. Rothman KJ. Causes. American Journal of Epidemiology 104: 587-592, 1976.
222. Rothman KJ. Modern epidemiology. Boston: Little, Brown, 1986.
223. Rothman KJ (ed). Causal inference. Chestnut Hill, Massachusetts: Epidemiology Resources, 1988.
224. Rothman KJ, Greenland S. Modern epidemiology. 2nd edn. Philadelphia: Lippincott-Raven, 1998.
225. Ruston A, Clayton J, Caiman M. Patients' action during their cardiac event: qualitative study exploring differences and modifiable factors. British Medical Journal 316: 1060-1064, 1998.
226. Sackett DL. Bias in analytic research. Journal of Chronic Diseases 32: 51-63, 1979.
227. Sackett DL, Haynes RB, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. Boston: Little, Brown, 1985.
228. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine: how to practice and teach EBM. New York: Churchill Livingstone, 1997.
229. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. New England Journal of Medicine 316: 450-455, 1987.
230. Schlesselman JJ. Case-control studies: design, conduct, analysis. New York: Oxford University Press, 1982.
231. Schull WJ, Cobb S. The intrafamilial transmission of rheumatoid arthritis-III. The lack of support for a genetic hypothesis. Journal of Chronic Diseases 22: 217-222, 1969.
232. Scrimshaw SCM, Hurtado E. Rapid assessment procedures for nutrition and primary health care: anthropological approaches to improving program effectiveness. Los Angeles: UCLA Latin American Center Publications, 1987.
233. Selvin S. Statistical analysis of epidemiologic data, 2nd edn. New York: Oxford University Press, 1996.
234. Severson RK, Linet MS. Does cigarette smoking lead to the subsequent development of leukemia? Archives of Internal Medicine 153: 425-427, 1993.
235. Shakespeare W. Hamlet, prince of Denmark. 1603.
236. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer 39 (Suppl. 6): 2772-2782, 1977.
237. Shapiro S, Slone D, Rosenberg L, Kaufman DW, Stolley PD, Miettinen OS. Oralcontraceptive use in relation to myocardial infarction. Lancet 1: 743-747, 1979.
238. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten-to fourteen-year effect of screening on breast cancer mortality. Journal of the National Cancer Institute 69: 349-355, 1982.
239. Shirlow MJ, Mathers CD. Caffeine consumption and serum cholesterol levels. International Journal of Epidemiology 13: 422-427, 1984.
240. Shirlow MJ, Mathers CD. A study of caffeine consumption and symptoms: indigestion, palpitations, tremor, headache and insomnia. International Journal of Epidemiology 14: 239-248, 1985.
241. Shoukri MM. Agreement, measurement of. In: Encyclopedia of epidemiologic methods (Gail MH, Benichou J, eds). Chichester: Wiley, 2000, pp. 35-49.
242. Shoukri MM, Pause CA. Statistical methods for health sciences, 2nd edn. Boca Raton, Florida: CRC Press, 1998.
243. Siegel S, Castellan NJ Jr. Nonparametric statistics for the behavioral sciences, 2nd edn. New York: McGraw-Hill, 1988.
244. Siegel-Itzkovich J. "Distortion" of passive smoking evidence provokes controversy in Israel. British Medical Journal 320: 626, 2000.
245. Simon R. A decade of progress in statistical methodology for clinical trials. Statistics in Medicine 10: 1789-1817, 1991.
246. Slavin RE. Best-evidence synthesis: an alternative approach to traditional and metaanalytic reviews. Educational Researcher 15(9): 5-11, 1986.
247. Slavin RE. Best-evidence synthesis: why less is more. Educational Researcher 16(5): 15-16, 1987.
248. Smith GD, Harding S, Rosato M. Relation between infants' birth weight and mothers' mortality: prospective observational study. British Medical Journal 320: 839-840, 2000.
249. Smith GD, Phillips AN, Neaton JD. Smoking as "independent" risk factor for suicide: illustration of an artifact from observational epidemiology? Lancet 340: 709-712, 1992.
250. Smith ML, Glass GV. Meta-analysis of psychotherapy outcome studies. American Psychologist 35: 752-760, 1977.
251. Smith PG, Rodriguez LC, Fine PEM. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. International Journal of Epidemiology 13: 87-93, 1984.
252. Sommer A. Epidemiology and statistics for the ophthalmologist. New York: Oxford University Press, 1980.
253. Sosenko JM, Gardner LB. Attribute frequency and misclassification bias. Journal of Chronic Diseases 40: 203-207, 1987.
254. Spitzer WO. Meta-meta-analysis: unanswered questions about aggregating data. Journal of Clinical Epidemiology 44: 103-107, 1991.
255. Sprackling ME, Mitchell JRA, Short AH, Watt G. Blood pressure reduction in the elderly: a randomised controlled trial of methyldopa. British Medical Journal 283: 1151-1153, 1981.
256. Stampfer MJ, Goldhaber SZ, Yusuf S, Peto R, Hennekens CH. Intravenous streptokinase for acute myocardial infarction. New England Journal of Medicine 308: 593-594, 1982.
257. Stark CR, Mantel N. Effects of maternal age and birth order on the risk of mongolism and leukemia. Journal of the National Cancer Institute 37: 687-698, 1966.
258. Stellman SD, Garfinkel L. Artificial sweetener use and one-year weight change among women. Preventive Medicine 15: 195-202, 1986.
259. Stern JM, Simes RJ. Publication bias: evidence of delayed publication in a cohort study of clinical regression projects. British Medical Journal 315: 640-645, 1997.
260. Stewart AL, Ware JE Jr, Brook R, Davies-Avery A. Conceptualization and measurement of health for adults in the Health Insurance Study, Vol. II: Physical health in terms of functioning. Santa Monica, California: Rand Corporation, 1978.
261. Stewart AW, Jackson RT, Ford MA, Beaglehole R. Underestimation of relative weight by use of self-reported height and weight. American Journal of Epidemiology 125: 122-126, 1987.
262. Stewart LA, Parmar MKB. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet 341: 418-422, 1993.
263. Stouffer SA, Suchman EA, De Vinney LC, Star SA, Williams RM Jr. The American soldier: adjustment during army life, Vol. 1. Princeton, New Jersey: Princeton University Press, 1949.
264. Sukwa TY, Bulsara MK, Wurapa FK. The relationship between morbidity and intensity of Schistosoma mansoni infection in a rural Zambian community. International Journal of Epidemiology 15: 248-251, 1986.
265. Susser M. Causal thinking in the health sciences: concepts and strategies in epidemiology. New York: Oxford University Press, 1973.
266. Susser M. The logic of Sir Karl Popper and the practice of epidemiology. American Journal of Epidemiology 124: 711-718, 1986.
267. Susser M. Falsification, verification, and causal inference in epidemiology: reconsiderations in the light of Sir Karl Popper's philosophy. In: Epidemiology, health, & society (Susser M, ed). New York: Oxford University Press, 1987. [Also in: Rothman KJ (3d). Causal inference. Chestnut Hill, Massachusetts: Epidemiology Resources, 1988, pp. 33-57.]
268. Susser M. Rational science versus a system of logic. In: Causal inference (Rothman KJ, ed). Chestnut Hill, Massachusetts: Epidemiology Resources, 1988, pp. 189-199.
269. Susser M. Choosing a future for epidemiology: II. From black box to Chinese boxes and ecoepidemiology. American Journal of Public Health 86: 674-677, 1996.
270. Ter Riet G, Kleijnen J, Knipschild P. Acupuncture and chronic pain: a criteria-based metaanalysis. Journal of Clinical Epidemiology 43: 1191-1199, 1990.
271. Thompson SG, Pocock SJ. Can meta-analyses be trusted? Lancet 338: 1127-1130, 1991.
272. Tillett HE. Statistical analysis of case-control studies of communicable diseases. International Journal of Epidemiology 15: 126-133, 1986.
273. Tuomilehto J, Morelos S, Yason J, Guzman SV, Geizerova H. Trends in cardiovascular disease mortality in the Philippines. International Journal of Epidemiology 13: 168-176, 1984.
274. Turner JA, Herron L, Deyo RA. Meta-analysis of the results of lumbar spine fusion. Acta Orthopaedica Scandinavica 64 (Suppl. 251): 120-122, 1993.
275. Udjo EO. Additional evidence regarding fertility and mortality trends in South Africa and implications for population projections. Mimeo. Pretoria: Statistics South Africa, 1998. On Internet:
276. U.S. Preventive Services Task Force. Guide to clinical preventive services, 2nd edn. Washington, D.C.: U.S. Department of Health and Human Services, undated.
277. Walker AM. Reporting the results of epidemiologic studies. American Journal of Public Health 76: 556-558, 1986.
278. Weddell JM, McDougall A. Road traffic accidents in Sharjah. International Journal of Epidemiology 10: 155-159, 1981.
279. Weinberg CR. Toward a clearer definition of confounding. American Journal of Epidemiology 137: 1-8, 1993.
280. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Statistics in Medicine 10: 1665-1677, 1991.
281. WHO Expert Committee on Diabetes Mellitus. Second report. WHO Technical Report Series No. 646, Geneva: WHO, 1980.
282. Wolf FM. Meta-analysis: quantitative methods for research synthesis. Beverly Hills, California: Sage Publications, 1986.
283. Wortman PM, Yeaton WH. Synthesis of results in controlled clinical trials of coronary bypass graft surgery. In: Evaluation studies review annual, Vol. 8 (LIght RJ, ed). Beverly Hills, California: Sage Publications, 1983.
284. Yusuf S. Obtaining medically meaningful answers from an overview of randomized clinical trials. Statistics in Medicine 6: 281-286, 1987a.
285. Yusuf S. Discussion. Statistics in Medicine 6: 287-294, 1987b.
286. Yusuf S, Held P, Furburg CD. Update of effects of calcium antagonists in myocardial infarction or angina in light of the Second Danish Verapamil Infarction Trial (DAVIT-II) and othe recent studies. American Journal of Cardiology 67: 1295-1297, 1991.
287. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progress in Cardiovascular Diseases 27: 335-371, 1985.
288. Yusuf S, Simon R, Ellenberg S. (eds). Proceedings of "Methodologic Issues in Overviews of Randomized Clinical Trials." Statistics in Medicine 6: 217-409, 1987.
289. Zelen M. Guidelines for publishing papers on cancer clinical trials: responsibilities of editors and authors. Journal of Clinical Oncology 1: 164-169, 1983.
290. Zoloth S, Michaels D, Lacher M, Nagin D, Drucker E. Asbestos disease screening by nonspecialists: results of an evaluation. American Journal of Public Health 76: 1392-1395, 1986.